Shyamala Maheswaran
Harvard University
H-index: 80
North America-United States
Top articles of Shyamala Maheswaran
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product | bioRxiv | Avanish Mishra Shih-Bo Huang Taronish Dubash Risa Burr Ben S Wittner | 2024 |
Digital Analysis of Circulating Tumor Cells in Blood Samples | 2024/2/13 | ||
CDKN1B (p27kip1) enhances drug tolerant persister CTCs by restricting polyploidy following mitotic inhibitors. | bioRxiv | Elad Horwitz Taronish Dorab Dubash Anna Szabolcs Ben S Wittner Johannes Kreuzer | 2024 |
Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial | Annals of Oncology | LM Spring SM Tolaney G Fell V Bossuyt RO Abelman | 2024/3/1 |
Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer | JCO Precision Oncology | Philip J Saylor Keisuke Otani Rene Balza Jacob Ukleja Haley Pleskow | 2024/2 |
Methods relating to circulating tumor cell clusters and the treatment of cancer | 2024/1/11 | ||
DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs | Cell | Hongshan Guo Joanna A Vuille Ben S Wittner Emily M Lachtara Yu Hou | 2023/6/22 |
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade | NPJ Precision Oncology | Douglas B Fox Richard Y Ebright Xin Hong Hunter C Russell Hongshan Guo | 2023/3/2 |
Abstract IA010: Hypomethylation of immune-related loci contribute to prostate tumorigenesis | Cancer Research | Daniel A Haber Hongshan Guo Ben S Wittner Joanna A Vuille Michael S Lawrence | 2023/1/15 |
A Gene Panel Associated With Abemaciclib Utility in ESR1-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression | JCO Precision Oncology | Jamie O Brett Taronish D Dubash Gabriela N Johnson Andrzej Niemierko Veronica Mariotti | 2023/5 |
DrugMap: A quantitative pan-cancer analysis of cysteine ligandability | Cell | Mariko Takahashi Harrison B Chong Siwen Zhang Tzu-Yi Yang Matthew J Lazarov | 2023/10/23 |
Abstract CT073: Efficacy of novel oral SERD elacestrant in fulvestrant-refractory hormone receptor-positive (HR+) breast cancer: a translational investigation | Cancer Research | Taronish D Dubash Aditya Bardia Brian Chirn Brittany A Reeves Joseph A LiCausi | 2023/4/14 |
Germline mutations and developmental mosaicism underlying EGFR-mutant lung cancer | medRxiv | Risa Burr Ignaty Leshchiner Christina L Costantino Martin Blohmer Tilak Sundaresan | 2023/9/29 |
Mechanisms of genetic predisposition to multifocal lung cancer | Cancer Research | Risa Burr Ignaty Leshchiner Christina L Costantino Martin Blohmer Tilak Sundaresan | 2023/4/4 |
Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cells | Breast Cancer Research and Treatment | Taronish D Dubash Aditya Bardia Brian Chirn Brittany A Reeves Joseph A LiCausi | 2023/8 |
TGF-β in the microenvironment induces a physiologically occurring immune-suppressive senescent state | Cell reports | Satoru Matsuda Ajinkya Revandkar Taronish D Dubash Arvind Ravi Ben S Wittner | 2023/3/28 |
Biomarkers of Cancer | 2022/3/31 | ||
Differential kinase activity across prostate tumor compartments defines sensitivity to target inhibition | Cancer research | Nezihi Murat Karabacak Yu Zheng Taronish D Dubash Risa Burr Douglas S Micalizzi | 2022/3/15 |
Negative-selection enrichment of circulating tumor cells from peripheral blood using the microfluidic CTC-iChip | Risa Burr Jon F Edd Brian Chirn Avanish Mishra Daniel A Haber | 2022/2/17 | |
Digital Analysis of Blood Samples to Determine Efficacy of Cancer Therapies for Specific Cancers | 2022/11/17 |
